Fill 1 Return To RT

Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment

Table of Contents

This activity is supported by an unrestricted educational grant from Orasis Pharmaceuticals.

September 2025 Supplement

Consensus Panel Highlights: Pharmacotherapy for Presbyopia and Considerations for the Posterior Segment

Share:

September 2025 Supplement cover

View Supplement